risk versus reward, page-6

  1. 2,633 Posts.
    lightbulb Created with Sketch. 169
    Why has CMQ not brought in a large commercial partner how could more effectively market the drug? For example Du Pont? What don't they want people to see?


    hi munch

    the costs to go it alone are not too high.so why settle for a 5% royalty when you could get a 80% gross margin.
    marketing-there are very few major producers in each country.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.